Search research articles
Contact Us
Filters
Showing results (461-470 of 1,063) with videos related to
Page
of 107
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor
M Raymond V Finlay, David Buttar, Susan E Critchlow, et al.
Molecular Ecology
|
March 7, 2000
Disparate phylogeographic patterns of molecular genetic variation in four closely related South American small cat species
W E Johnson, J P Slattery, E Eizirik, et al.
Clinical Lung Cancer
|
November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer
Ray D Page, Leylah M Drusbosky, Hiba Dada, et al.
JCO Precision Oncology
|
September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer
Benny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Inherited Metabolic Disease
|
June 18, 2022
ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines
Daniah Albokhari, Bobby G Ng, Alis Guberinic, et al.
Clinical Breast Cancer
|
July 25, 2008
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group
John T Hamm, John W Wilson, Priya Rastogi, et al.
Journal of Medicinal Chemistry
|
November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors
Jason D Shields, Brian M Aquila, David Emmons, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 1999
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension
P Calés, F Oberti, J L Payen, et al.
JCO Precision Oncology
|
September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA
Nora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway Aberrations
Thereasa A Rich, Karen L Reckamp, Young Kwang Chae, et al.
Page
of 107
Search research articles
Search
Showing results (461-470 of 1,063) with videos related to
Sort By:
Page
of 107
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor
M Raymond V Finlay, David Buttar, Susan E Critchlow, et al.
Molecular Ecology
|
March 7, 2000
Disparate phylogeographic patterns of molecular genetic variation in four closely related South American small cat species
W E Johnson, J P Slattery, E Eizirik, et al.
Clinical Lung Cancer
|
November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer
Ray D Page, Leylah M Drusbosky, Hiba Dada, et al.
JCO Precision Oncology
|
September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer
Benny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.
Journal of Inherited Metabolic Disease
|
June 18, 2022
ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines
Daniah Albokhari, Bobby G Ng, Alis Guberinic, et al.
Clinical Breast Cancer
|
July 25, 2008
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group
John T Hamm, John W Wilson, Priya Rastogi, et al.
Journal of Medicinal Chemistry
|
November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors
Jason D Shields, Brian M Aquila, David Emmons, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 1999
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension
P Calés, F Oberti, J L Payen, et al.
JCO Precision Oncology
|
September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNA
Nora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway Aberrations
Thereasa A Rich, Karen L Reckamp, Young Kwang Chae, et al.
Page
of 107